Stephen A. Beers

5.5k total citations
68 papers, 3.5k citations indexed

About

Stephen A. Beers is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Stephen A. Beers has authored 68 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Radiology, Nuclear Medicine and Imaging, 32 papers in Immunology and 25 papers in Oncology. Recurrent topics in Stephen A. Beers's work include Monoclonal and Polyclonal Antibodies Research (43 papers), T-cell and B-cell Immunology (14 papers) and Immune Cell Function and Interaction (13 papers). Stephen A. Beers is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (43 papers), T-cell and B-cell Immunology (14 papers) and Immune Cell Function and Interaction (13 papers). Stephen A. Beers collaborates with scholars based in United Kingdom, United States and Netherlands. Stephen A. Beers's co-authors include Mark S. Cragg, Martin J. Glennie, Ruth R. French, H.T. Claude Chan, Peter Johnson, Sean H. Lim, Ann L. White, Kerry L. Cox, Ali Roghanian and C. Ian Mockridge and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Stephen A. Beers

67 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen A. Beers United Kingdom 29 1.7k 1.7k 1.1k 974 909 68 3.5k
Ruth R. French United Kingdom 32 2.7k 1.5× 2.3k 1.3× 1.5k 1.3× 1.1k 1.1× 1.0k 1.1× 58 4.5k
Pablo Umaña Switzerland 32 2.3k 1.3× 2.7k 1.6× 1.8k 1.6× 2.4k 2.5× 678 0.7× 119 5.2k
Kerry Klussman United States 19 1.8k 1.0× 938 0.5× 1.4k 1.2× 792 0.8× 201 0.2× 37 3.4k
Julie P. Deans Canada 29 1.2k 0.7× 797 0.5× 483 0.4× 971 1.0× 413 0.5× 47 2.5k
Sarah A. Bixler United States 15 2.6k 1.5× 678 0.4× 659 0.6× 1.1k 1.2× 302 0.3× 19 4.4k
Craig Okada United States 20 1.7k 1.0× 407 0.2× 749 0.7× 760 0.8× 249 0.3× 49 2.6k
Jerry W. Slootstra Netherlands 19 737 0.4× 800 0.5× 826 0.7× 1.0k 1.1× 467 0.5× 35 2.5k
Fumiko Arakawa Japan 23 603 0.3× 468 0.3× 1.2k 1.0× 572 0.6× 373 0.4× 98 2.3k
Rudolf Schmits Germany 25 2.7k 1.6× 515 0.3× 1.1k 1.0× 1.4k 1.4× 221 0.2× 52 4.5k
Hassan Jumaa Germany 45 3.4k 2.0× 563 0.3× 939 0.8× 2.7k 2.7× 1.5k 1.7× 133 6.6k

Countries citing papers authored by Stephen A. Beers

Since Specialization
Citations

This map shows the geographic impact of Stephen A. Beers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen A. Beers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen A. Beers more than expected).

Fields of papers citing papers by Stephen A. Beers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen A. Beers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen A. Beers. The network helps show where Stephen A. Beers may publish in the future.

Co-authorship network of co-authors of Stephen A. Beers

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen A. Beers. A scholar is included among the top collaborators of Stephen A. Beers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen A. Beers. Stephen A. Beers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Hannah, Russell B. Foxall, Patrick J. Duriez, et al.. (2025). Comparison of human macrophages derived from peripheral blood and bone marrow. The Journal of Immunology. 214(4). 714–725. 4 indexed citations
2.
Birts, Charles N., et al.. (2023). The role of three-dimensional in vitro models in modelling the inflammatory microenvironment associated with obesity in breast cancer. Breast Cancer Research. 25(1). 104–104. 7 indexed citations
3.
Savva, Constantinos, Ellen Copson, Peter Johnson, Ramsey Cutress, & Stephen A. Beers. (2023). Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Strategies. Cancers. 15(9). 2440–2440. 10 indexed citations
4.
Lim, Sean H., Stephen A. Beers, Aymen Al‐Shamkhani, & Mark S. Cragg. (2023). Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges. Clinical Cancer Research. 30(9). 1712–1723. 9 indexed citations
5.
Roghanian, Ali, Robert Oldham, H.T. Claude Chan, et al.. (2022). FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms. Cell Reports. 40(3). 111099–111099. 16 indexed citations
6.
Chan, H.T. Claude, Michael J. Marshall, Christine A. Penfold, et al.. (2022). Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering. Communications Biology. 5(1). 229–229. 12 indexed citations
7.
Hussain, Khiyam, Mark S. Cragg, & Stephen A. Beers. (2021). Remodeling the Tumor Myeloid Landscape to Enhance Antitumor Antibody Immunotherapies. Cancers. 13(19). 4904–4904. 9 indexed citations
8.
Rowley, Tania F., Robert Oldham, Sonya James, et al.. (2021). On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation. Communications Biology. 4(1). 1031–1031. 17 indexed citations
9.
Oldham, Robert, et al.. (2020). Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment. SHILAP Revista de lepidopterología. 9(4). 64–64. 149 indexed citations
10.
Roghanian, Ali, Guangan Hu, Christophe Fraser, et al.. (2019). Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression. Cancer Immunology Research. 7(11). 1876–1890. 29 indexed citations
11.
Dahal, Lekh N., Lang Dou, Khiyam Hussain, et al.. (2017). STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy. Cancer Research. 77(13). 3619–3631. 59 indexed citations
12.
Dovedi, Simon J., Grazyna Lipowska‐Bhalla, Stephen A. Beers, et al.. (2016). Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells. Cancer Immunology Research. 4(7). 621–630. 44 indexed citations
13.
Vaughan, Andrew, Mark S. Cragg, & Stephen A. Beers. (2015). Antibody modulation: Limiting the efficacy of therapeutic antibodies. Pharmacological Research. 99. 269–275. 9 indexed citations
14.
Tipton, Tom, C. Ian Mockridge, Ruth R. French, et al.. (2015). Anti-mouse Fc?RIV antibody 9E9 also blocks Fc?RIII in vivo. Blood. 1 indexed citations
15.
Alduaij, Waleed, Andrei Ivanov, Jamie Honeychurch, et al.. (2011). Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies. Blood. 117(17). 4519–4529. 222 indexed citations
16.
Beers, Stephen A., Ruth R. French, H.T. Claude Chan, et al.. (2010). Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection. Blood. 115(25). 5191–5201. 241 indexed citations
17.
Beers, Stephen A., H.T. Claude Chan, Ruth R. French, Mark S. Cragg, & Martin J. Glennie. (2010). CD20 as a Target for Therapeutic Type I and II Monoclonal Antibodies. Seminars in Hematology. 47(2). 107–114. 167 indexed citations
18.
Walshe, Claire A., Stephen A. Beers, Ruth R. French, et al.. (2008). Induction of Cytosolic Calcium Flux by CD20 Is Dependent upon B Cell Antigen Receptor Signaling. Journal of Biological Chemistry. 283(25). 16971–16984. 117 indexed citations
19.
Teeling, Jessica L., Wendy J.M. Mackus, Stephen A. Beers, et al.. (2006). The Biological Activity of Human CD20 Monoclonal Antibodies Is Linked to Unique Epitopes on CD20. The Journal of Immunology. 177(1). 362–371. 466 indexed citations
20.
Beers, Stephen A., Andrew G Buckland, Rao S. Koduri, et al.. (2002). The Antibacterial Properties of Secreted Phospholipases A2. Journal of Biological Chemistry. 277(3). 1788–1793. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth R. French Breakdown of academic impact, for papers by Pablo Umaña Breakdown of academic impact, for papers by Kerry Klussman Breakdown of academic impact, for papers by Julie P. Deans Breakdown of academic impact, for papers by Sarah A. Bixler Breakdown of academic impact, for papers by Craig Okada Breakdown of academic impact, for papers by Jerry W. Slootstra Breakdown of academic impact, for papers by Fumiko Arakawa Breakdown of academic impact, for papers by Rudolf Schmits Breakdown of academic impact, for papers by Hassan Jumaa
Rankless by CCL
2026